Friday, February 14, 2025
HomeNewsBelfast Life Sciences Firm Launches Funding Drive

Belfast Life Sciences Firm Launches Funding Drive

Belfast-based ProAxsis, backed by VC group EMV Capital, has launched a fund raise of up to £800,000 to drive commercial expansion and clinical progress in chronic respiratory disease.

A spin-out from Queen’s University, ProAxsis is a respiratory diagnostics company specialising in biomarker-based tests for chronic lung diseases like COPD, cystic fibrosis, and bronchiectasis. 

The company recently doubled revenues and is now gearing up for a major clinical study on its NEATstik® platform with Imperial College London.

EMV Capital plc (AIM: EMVC) is a London-based deeptech and life sciences VC investment group.

Join our mailing list

Sign up to receive the latest news, opinion and blog entries from Business Eye

RELATED ARTICLES
- Advertisment -

Most Read

- Advertisment -
- Advertisment -